DSpace Repository

3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: Application of molecular field analysis

Show simple item record

dc.contributor.author Nunthanavanit P.
dc.contributor.author Anthony N.G.
dc.contributor.author Johnston B.F.
dc.contributor.author Mackay S.P.
dc.contributor.author Ungwitayatorn J.
dc.date.accessioned 2021-04-05T04:31:58Z
dc.date.available 2021-04-05T04:31:58Z
dc.date.issued 2008
dc.identifier.issn 3656233
dc.identifier.other 2-s2.0-50949092681
dc.identifier.uri https://ir.swu.ac.th/jspui/handle/123456789/14850
dc.identifier.uri https://www.scopus.com/inward/record.uri?eid=2-s2.0-50949092681&doi=10.1002%2fardp.200700229&partnerID=40&md5=2a49c59d1f6f111004e25d0b3640205e
dc.description.abstract Three-dimensional quantitative structure-activity relationship (3D-QSAR) models were developed for chromone derivatives against HIV-1 protease using molecular field analysis (MFA) with genetic partial least square algorithms (G/PLS). Three different alignment methods: field fit, pharmacophore-based, and receptor-based were used to derive three MFA models. All models produced good predictive ability with high cross-validated r2 (r2 cv), conventional r2, and predictive r2 (r 2pred) values. The receptor-based MFA showed the best statistical results with r2cv = 0.789, r2 = 0.886, and r2pred = 0.995. The result obtained from the receptor-based model was compared with the docking simulation of the most active compound 21 in this chromone series to the binding pocket of HIV-1 protease (PDB entry 1AJX). It was shown that the MFA model related well with the binding structure of the complex and can provide guidelines to design more potent HIV-1 protease inhibitors. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA.
dc.subject chromone derivative
dc.subject proteinase inhibitor
dc.subject chromone derivative
dc.subject p16 protease, Human immunodeficiency virus 1
dc.subject proteinase
dc.subject proteinase inhibitor
dc.subject article
dc.subject drug protein binding
dc.subject molecular model
dc.subject pharmacophore
dc.subject predictive validity
dc.subject priority journal
dc.subject quantitative structure activity relation
dc.subject simulation
dc.subject three dimensional imaging
dc.subject algorithm
dc.subject binding site
dc.subject chemical structure
dc.subject chemistry
dc.subject conformation
dc.subject drug design
dc.subject regression analysis
dc.subject Algorithms
dc.subject Binding Sites
dc.subject Chromones
dc.subject Drug Design
dc.subject HIV Protease
dc.subject HIV Protease Inhibitors
dc.subject Least-Squares Analysis
dc.subject Models, Molecular
dc.subject Molecular Conformation
dc.subject Quantitative Structure-Activity Relationship
dc.title 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: Application of molecular field analysis
dc.type Article
dc.rights.holder Scopus
dc.identifier.bibliograpycitation Archiv der Pharmazie. Vol 341, No.6 (2008), p.357-364
dc.identifier.doi 10.1002/ardp.200700229


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics